Janux Therapeutics Insider Trades
NASDAQ: JANXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 10 · $457.07K
- Shares bought / sold
- 0 / 28.46K
- Net activity
- Net selling $457,074
Janux Therapeutics insider activity
Over the last 12 months, Janux Therapeutics insiders reported 27 transactions on SEC Form 4: 0 open-market purchases and 10 sales. Insiders bought $0 and sold $457,074 worth of stock, for net insider selling of $457,074. The largest seller was Meyer Andrew Hollman, with $135,728 in reported sales.
The most recent filing shows Campbell David Alan (President and CEO) reporting a transaction in 123,840 shares on Jul 31, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put JANX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
JANX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 31, 2026 | Campbell David AlanPresident and CEO | Gift | 123,840 | — | Form 4 |
| Jul 8, 2026 | Campbell David AlanPresident and CEO | Option exercise | 7,000 | $29.47K | Form 4 |
| Jun 11, 2026 | Simson JakeDirector | Award | 5,500 | — | Form 4 |
| Jun 11, 2026 | Barrett Ronald WDirector | Award | 5,500 | — | Form 4 |
| Jun 11, 2026 | CAPPS VICKIE LDirector | Award | 5,500 | — | Form 4 |
| Jun 11, 2026 | DOBMEIER ERICDirector | Award | 5,500 | — | Form 4 |
| Jun 11, 2026 | Hernday NatashaDirector | Award | 5,500 | — | Form 4 |
| Jun 11, 2026 | Kung WinstonDirector | Award | 5,500 | — | Form 4 |
| Jun 11, 2026 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Award | 5,500 | — | Form 4 |
| Jun 2, 2026 | Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr | Sale | 4,059 | $56.94K | Form 4 |
| May 11, 2026 | Dobek MariaVice President, Accounting | Sale | 2,038 | $28.88K | Form 4 |
| Feb 2, 2026 | Go WilliamChief Medical Officer | Award | 44,000 | — | Form 4 |
| Jan 2, 2026 | Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr | Award | 36,000 | — | Form 4 |
| Jan 2, 2026 | McIver ZachariahChief Medical Officer | Award | 29,000 | — | Form 4 |
| Jan 2, 2026 | McIver ZachariahChief Medical Officer | Sale | 2,714 | $37.26K | Form 4 |
| Jan 2, 2026 | Campbell David AlanPresident and CEO | Award | 96,600 | — | Form 4 |
| Jan 2, 2026 | Campbell David AlanPresident and CEO | Sale | 8,072 | $110.83K | Form 4 |
| Jan 2, 2026 | Dobek MariaVice President, Accounting | Award | 18,935 | — | Form 4 |
| Jan 2, 2026 | Dobek MariaVice President, Accounting | Sale | 1,462 | $20.07K | Form 4 |
| Jan 2, 2026 | Winter Charles M.Chief Technical Officer | Award | 28,600 | — | Form 4 |
| Jan 2, 2026 | Winter Charles M.Chief Technical Officer | Sale | 2,401 | $32.97K | Form 4 |
| Jan 2, 2026 | DiRaimondo ThomasChief Scientific Officer | Award | 31,400 | — | Form 4 |
| Jan 2, 2026 | DiRaimondo ThomasChief Scientific Officer | Sale | 2,505 | $34.39K | Form 4 |
| Jan 2, 2026 | Meyer Andrew HollmanChief Business Officer | Sale | 1,879 | $25.80K | Form 4 |
| Dec 1, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 633 | $21.22K | Form 4 |
| Dec 1, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 2,700 | $88.71K | Form 4 |
| Dec 1, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 3,333 | $35.30K | Form 4 |
| Nov 14, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 3,333 | $99.99K | Form 4 |
| Nov 14, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 3,333 | $35.30K | Form 4 |
| Oct 28, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 16,665 | $500.99K | Form 4 |
| Oct 28, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 6,666 | $70.59K | Form 4 |
| Oct 28, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 9,999 | $42.10K | Form 4 |
| Jun 11, 2025 | Hernday NatashaDirector | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | Gujrathi SheilaDirector | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | DOBMEIER ERICDirector | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | Kung WinstonDirector | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | Simson JakeDirector | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | McNulty Alana B.Director | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | Barrett Ronald WDirector | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | CAPPS VICKIE LDirector | Award | 3,750 | — | Form 4 |
| Jun 11, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Award | 3,750 | — | Form 4 |
| Jun 2, 2025 | Doyle Janeen NoelChief Corp. & Bus. Dev. Ofcr | Award | 44,000 | — | Form 4 |
| May 1, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 400 | $13.04K | Form 4 |
| May 1, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 2,933 | $93.70K | Form 4 |
| May 1, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 3,333 | $14.03K | Form 4 |
| Apr 21, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 3,334 | $100.02K | Form 4 |
| Apr 21, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 3,334 | $14.04K | Form 4 |
| Mar 7, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 110,206 | $3.42M | Form 4 |
| Mar 6, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 372,093 | $11.45M | Form 4 |
| Mar 5, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 37,455 | $1.17M | Form 4 |
| Mar 5, 2025 | RA CAPITAL MANAGEMENT, L.P. & RA Capital Healthcare Fund LP & RA Capital Nexus Fund II, L.P. & Kolchinsky Peter & Shah Rajeev M.Director | Buy | 304,287 | $9.30M | Form 4 |
| Mar 3, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 901 | $29.60K | Form 4 |
| Mar 3, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 2,433 | $77.58K | Form 4 |
| Mar 3, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 3,334 | $14.04K | Form 4 |
| Feb 3, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 100 | $4.36K | Form 4 |
| Feb 3, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 816 | $34.90K | Form 4 |
| Feb 3, 2025 | Meyer Andrew HollmanChief Business Officer | Sale | 2,418 | $101.74K | Form 4 |
| Feb 3, 2025 | Meyer Andrew HollmanChief Business Officer | Option exercise | 3,334 | $14.04K | Form 4 |
| Jan 7, 2025 | Campbell David AlanPresident and CEO | Sale | 5,000 | $300.00K | Form 4 |
| Jan 2, 2025 | Winter Charles M.Chief Technical Officer | Award | 23,000 | — | Form 4 |
| Jan 2, 2025 | McIver ZachariahChief Medical Officer | Award | 26,000 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4